Cite
HARVARD Citation
Stewart, J. et al. (n.d.). 409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO). Journal for immunotherapy of cancer. p. A434. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stewart, J. et al. (n.d.). 409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO). Journal for immunotherapy of cancer. p. A434. [Online].